Literature DB >> 11391304

Dipyridamole-induced increased glucose uptake in patients with single-vessel coronary artery disease assessed with PET.

L I Araujo1, E O McFalls, A A Lammertsma, T Jones, A Maseri.   

Abstract

BACKGROUND: The aim of this study was to determine the relationship between vasodilatation-induced ischemia and poststress glucose uptake. Coronary vasodilators may induce myocardial ischemia due to coronary steal through collateral circulation or transmural blood flow redistribution with diminished subendocardial perfusion. Myocardial ischemia can be demonstrated by increased glucose uptake as previously shown in patients with exercise-induced ischemia. METHODS AND
RESULTS: We studied 11 patients with single-vessel disease and no history of myocardial infarction. Five patients had no collateral circulation, and 6 had angiographic evidence of collateral vessels. We measured myocardial blood flow (MBF) and glucose uptake at baseline and after the administration of dipyridamole (0.56 mg/kg) with positron emission tomography, using O-15 water and fluorine 18 deoxyglucose (FDG) as perfusion and glucose tracers. MBF at baseline was 0.82 +/- 0.13 mL/g/min in normal areas and 0.80 +/- 0.15 mL/g/min in areas supplied by stenotic arteries. MBF during dipyridamole was 2.05 +/- 0.66 and 1.19 +/- 0.66 mL/g/min in normal areas and areas with stenotic arteries, respectively (P < or = .001). FDG uptake at baseline was 1.36 +/- 0.55 in normal areas and 1.57 +/- 0.62 in areas supplied by stenotic arteries. FDG uptake after dipyridamole infusion was 1.79 +/- 1.1 and 4.04 +/- 0.84 in normal areas and areas with stenotic arteries, respectively (P < or =.001). MBF and FDG uptake were not different between patients with collateral circulation and those without collateral circulation.
CONCLUSIONS: Increased myocardial glucose uptake was consistently observed after dipyridamole administration in those areas with diminished coronary vasodilatory capacity. The similar MBF and FDG findings in patients with and without collateral circulation may indicate that transmural blood flow redistribution appears to be a possible mechanism of dipyridamole-induced myocardial ischemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11391304     DOI: 10.1067/mnc.2001.113615

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  15 in total

1.  Sustained nonoxidative glucose utilization and depletion of glycogen in reperfused canine myocardium.

Authors:  M Schwaiger; R A Neese; L Araujo; W Wyns; J A Wisneski; H Sochor; S Swank; D Kulber; C Selin; M Phelps
Journal:  J Am Coll Cardiol       Date:  1989-03-01       Impact factor: 24.094

2.  Increased sarcolemmal glucose transporter abundance in myocardial ischemia.

Authors:  F C Brosius; N Nguyen; S Egert; Z Lin; G M Deeb; F Haas; M Schwaiger; D Sun
Journal:  Am J Cardiol       Date:  1997-08-04       Impact factor: 2.778

3.  Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation.

Authors:  B L Gerber; J L Vanoverschelde; A Bol; C Michel; D Labar; W Wijns; J A Melin
Journal:  Circulation       Date:  1996-08-15       Impact factor: 29.690

Review 4.  Myocardial utilization of carbohydrate and lipids.

Authors:  J R Neely; M J Rovetto; J F Oram
Journal:  Prog Cardiovasc Dis       Date:  1972 Nov-Dec       Impact factor: 8.194

5.  Conditions for vasodilator-induced coronary steal in experimental myocardial ischemia.

Authors:  L C Becker
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

6.  Dipyridamole-induced ST segment depression during thallium-201 imaging in patients with coronary artery disease: angiographic and hemodynamic determinants.

Authors:  C E Chambers; K A Brown
Journal:  J Am Coll Cardiol       Date:  1988-07       Impact factor: 24.094

7.  Dipyridamole echocardiography test. A new tool for detecting jeopardized myocardium after thrombolytic therapy.

Authors:  L Bolognese; G Sarasso; A S Bongo; L Rossi; D Aralda; C Piccinino; P Rossi
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

8.  Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography.

Authors:  L I Araujo; A A Lammertsma; C G Rhodes; E O McFalls; H Iida; E Rechavia; A Galassi; R De Silva; T Jones; A Maseri
Journal:  Circulation       Date:  1991-03       Impact factor: 29.690

9.  Adenosine potentiates insulin-stimulated myocardial glucose uptake in vivo.

Authors:  W R Law; R M Raymond
Journal:  Am J Physiol       Date:  1988-05

10.  Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina.

Authors:  P Camici; L I Araujo; T Spinks; A A Lammertsma; J C Kaski; M J Shea; A P Selwyn; T Jones; A Maseri
Journal:  Circulation       Date:  1986-07       Impact factor: 29.690

View more
  13 in total

1.  Risk stratification of the normal perfusion scan: does normal stress perfusion always mean very low risk?

Authors:  Seth Dahlberg; Jeffrey Leppo
Journal:  J Nucl Cardiol       Date:  2003 Jan-Feb       Impact factor: 5.952

2.  Is BMIPP a sensitive marker for myocardial ischaemic stress? For.

Authors:  Nagara Tamaki; Koichi Morita
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-27       Impact factor: 9.236

3.  Dipyridamole reverses peripheral ischemia and induces angiogenesis in the Db/Db diabetic mouse hind-limb model by decreasing oxidative stress.

Authors:  Christopher B Pattillo; Shyamal C Bir; Billy G Branch; Eric Greber; Xinggui Shen; Sibile Pardue; Rakesh P Patel; Christopher G Kevil
Journal:  Free Radic Biol Med       Date:  2010-11-09       Impact factor: 7.376

Review 4.  The Japanese experience with metabolic imaging in the clinical setting.

Authors:  Nagara Tamaki; Koichi Morita; Yuko Kawai
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

5.  Comparison of Tc-99m tetrofosmin myocardial perfusion scintigraphy and exercise F18-FDG imaging in detection of myocardial ischemia in patients with coronary artery disease.

Authors:  Sasikumar Arun; Bhagwant Rai Mittal; Anish Bhattacharya; Manoj Kumar Rohit
Journal:  J Nucl Cardiol       Date:  2014-08-15       Impact factor: 5.952

6.  Direct myocardial ischemia imaging with exercise ¹⁸FDG.

Authors:  Diwakar Jain; Zuo-Xiang He
Journal:  J Nucl Cardiol       Date:  2015-02       Impact factor: 5.952

Review 7.  Exercise (18)FDG imaging for the detection of CAD: What are the clinical hurdles?

Authors:  Diwakar Jain; Zuo-Xiang He; Afshin Ghanbarinia
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

Review 8.  Ischaemic memory imaging using metabolic radiopharmaceuticals: overview of clinical settings and ongoing investigations.

Authors:  Keiichiro Yoshinaga; Masanao Naya; Tohru Shiga; Eriko Suzuki; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-12       Impact factor: 9.236

9.  Direct imaging of myocardial ischemia: a potential new paradigm in nuclear cardiovascular imaging.

Authors:  Diwakar Jain; Zuo-Xiang He
Journal:  J Nucl Cardiol       Date:  2008 Sep-Oct       Impact factor: 5.952

10.  Effect of Dipyridamole Injected for Myocardial Perfusion Imaging on Blood Glucose Concentration; A Preliminary Study.

Authors:  Amirreza Khorasanchi; Mohsen Arabi; Alireza Akhavein; Mohammad Seyedabadi; Mansooreh Eftekhari; Hamid Javadi; Iraj Nabipour; Majid Assadi
Journal:  J Clin Diagn Res       Date:  2016-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.